This news release constitutes a “designated news release” for the purposes of the Company’s amended and restated prospectus supplement dated…
TORONTO, Sept. 19, 2025 (GLOBE NEWSWIRE) -- PharmAla Biotech Holdings Inc. (“PharmAla” or the “Company”) (CSE: MDMA) (OTC:MDXXF), a biotechnology…
Final Short-Form Base Shelf Prospectus Is accessible on SEDAR+ and EDGAR September 16, 2025 18:02 ET | Source: Intermap Technologies…
July 04, 2025 15:10 ET | Source: Spectral Medical Inc. TORONTO, July 04, 2025 (GLOBE NEWSWIRE) -- Spectral Medical Inc.…